Myriad Genetics Inc. (MYGN)

NASDAQ

$5.50

$+1.32

(+31.24%)

Regular Market

Myriad Genetics Inc. (MYGN) Live Price Chart

Last updated: ⁦2026-10-20 14:32:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Myriad Genetics Inc. (MYGN) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $5.50, with a market capitalization of $380.69M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.74 to $8.50. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$380.69M
Open	$5.34
Day's High	$50.44
Day's Low	$2.74
Previous Close	$4.21
Volume	13.12M
Average Volume	2.12M
P/E Ratio	--
52-Week High	$8.50
52-Week Low	$2.74
Dividend Yield	--
Earnings Date	--

Myriad Genetics Inc. (MYGN) Stock Price Today

Myriad Genetics Inc. (MYGN) is currently trading at $5.50 as of 2026-10-20 14:16:50, up 30.71% ($1.29) from the previous close of $4.21

During today's regular trading session, MYGN has traded between $2.74 and $50.44, with a trading volume of 13.12M shares. The current price is near the lower end of today's range.

Myriad Genetics Inc. (MYGN) 7-Day Stock Price Change

Over the past seven days, Myriad Genetics Inc. (MYGN) moved from $4.31 to $5.50, representing a gain of 27.68% ($1.19).

The stock traded between $3.95 and $5.92 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 1.41 million shares, down versus the previous seven-day period, indicating lower trading activity.

MYGN 52-Week Price Position

Position in Range: 48.0%

52W Low$2.74

52W High$8.50

MYGN is currently trading at $5.50, placing it 48.0% of the way from its 52-week low of $2.74 to its 52-week high of $8.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Myriad Genetics Inc. (MYGN)?

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Myriad Genetics Inc. Information

Industry	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees	2700
Exchange	NASDAQ
Company Website	https://www.myriad.com

How to Buy Myriad Genetics Inc. (MYGN) Stock on MEXC

Eligible investors can buy real shares of Myriad Genetics Inc. (MYGN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MYGN and Place Your Order

Open the RealStocks trading page and search for MYGN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Myriad Genetics Inc. (MYGN) stock price today?

Myriad Genetics Inc. (MYGN) is currently trading at $ 5.50, up 30.71% ($1.29) from the previous close of $ 4.21. Intraday prices update in real time during regular trading hours.

2.Is MYGN stock going up or down today?

As of 2026-10-20 14:16:50, MYGN is trading at $ 5.50, up 30.71% ($1.29) from its previous close of $ 4.21. The stock has traded between $ 2.74 and $ 50.44 during today’s regular session. Past price movements do not guarantee future results.

3.What is MYGN pre-market price?

As of 2026-10-20 14:16:50, MYGN is trading at $ 5.28 in pre-market trading, up 25.30% ($1.07) from the previous close of $ 4.21. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MYGN after-hours price?

As of 2026-10-20 14:16:50, MYGN is trading at $ 4.21 in after-hours trading, unchanged from the regular-session close of $ 4.21. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MYGN stock trading now?

MYGN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MYGN sit relative to its 52-week high and low?

Over the past 52 weeks, MYGN has traded between a low of $ 2.74 and a high of $ 8.50. At $ 5.50, the stock is positioned 48.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Myriad Genetics Inc. in?

Myriad Genetics Inc. (MYGN) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Myriad Genetics Inc.'s market capitalization and where is it listed?

Myriad Genetics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 380.69M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MYGN valued in terms of P/E ratio and EPS?

MYGN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.18. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Myriad Genetics Inc. pay a dividend?

Myriad Genetics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.